米鲁姆制药 MIRM
$93.72 +$0.18 (+0.19%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $93.72 0.00%
开盘$93.14
昨收$93.54
当日区间$91.18 – $95.68
成交量722.7K
市值$6.12B
市盈率（TTM）–
股息率–
财报
财报日平均波动±5.3%近16次财报
收涨次数8 / 1650% 的概率
最佳反应+12.0%
最差反应-15.1%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 5 Aug 2026 | After Market | ±9.3% | -11.04% | 超出定价预期 |
| 2026/Q1 | 6 May 2026 | After Market | ±6.1% | -6.50% | 超出定价预期 |
| 2025/Q4 | 25 Feb 2026 | After Market | ±8.1% | -15.13% | 超出定价预期 |
| 2025/Q3 | 4 Nov 2025 | After Market | ±9.6% | -1.24% | 符合区间 |
| 2025/Q2 | 6 Aug 2025 | After Market | ±9.4% | +12.04% | 超出定价预期 |
| 2025/Q1 | 7 May 2025 | After Market | ±8.6% | +9.75% | 超出定价预期 |
| 2024/Q4 | 26 Feb 2025 | After Market | ±12.7% | -7.02% | 符合区间 |
| 2024/Q3 | 12 Nov 2024 | Pre Market | – | +1.61% | – |
| 2024/Q2 | 7 Aug 2024 | After Market | ±14.7% | +2.34% | 符合区间 |
| 2024/Q1 | 8 May 2024 | After Market | ±8.6% | +3.16% | 符合区间 |
| 2023/Q4 | 28 Feb 2024 | After Market | ±20.0% | -0.62% | 符合区间 |
| 2023/Q3 | 2 Nov 2023 | After Market | ±18.7% | +5.67% | 符合区间 |
| 2023/Q2 | 3 Aug 2023 | After Market | ±10.3% | +6.31% | 符合区间 |
| 2023/Q1 | 4 May 2023 | Pre Market | ±16.5% | -2.59% | 符合区间 |
| 2022/Q4 | 8 Mar 2023 | Pre Market | ±12.7% | -0.13% | 符合区间 |
| 2022/Q3 | 9 Nov 2022 | After Market | ±22.1% | +0.20% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
营收构成
2026/Q2 季度
按业务线
基本面
最新报告季度：Q2, ended Jun 2026
营收$176.24M+37.9% YoY
营业利润-$26.10M-423.2% YoY
净利润-$67.23M-1,047.0% YoY
摊薄每股收益-$1.06-783.3% YoY
自由现金流-$69.28M-681.5% YoY
经营现金流-$44.25M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率81.7%
营业利润率-15.6%
净利率-139.2%
净资产收益率-703.0%
资产收益率-97.2%
投入资本回报率-129.7%
流动比率2.86
负债/资产比率101.0%
现金及投资$438.29M
总负债$760.54M
净现金（净负债）-$322.25M
暂无评论——快来第一个聊聊 MIRM。